Experimental animal models and their use in understanding cysticercosis: A systematic review.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 20 01 2022
accepted: 24 06 2022
entrez: 19 7 2022
pubmed: 20 7 2022
medline: 22 7 2022
Statut: epublish

Résumé

Cysticercosis and Neurocysticercosis (NCC) can be studied using several animal species in experimental models which contributes to the understanding of the human form of the disease. Experimental infections of Taenia spp. are vital in explaining the modes of transmission of the parasite and helps the understanding of transmission of the parasite in humans and thus may be useful in designing therapeutic and immune-prophylactic studies to combat the disease. Thus, this systematic review aims to explore the existing experimental animal models to the understanding of cysticercosis in both humans and animals and elucidate the risk factors of cysticercosis and identify the Taenia spp. used in these models. We systematically identified all publications from the Web of Science, Google Scholar, and Pubmed regarding experimental animal models using Taenia spp. that cause cysticercosis in both humans and animals. 58 studies were identified for eligibility. Of these, only 48 studies met the inclusion criteria from which data extraction was done and presented descriptively. Pigs, cattle, gerbils, mice, rats, voles, monkeys, cats, dogs, and goats were used in which T. solium, T. saginata, T. saginata asiatica, T. crassiceps and T. asiatica were studied. The routes used to induce disease were; oral, intravenous, subcutaneous, intramuscular, intraperitoneal, intraarterial, intracranial, intraduodenal, and surgical routes using eggs, oncospheres, and proglottids. Besides, the establishment of infection using eggs and oncospheres was affected by the route used to induce infection in the experimental animals. The cysticerci recovery rate in all the experimental studies was low and the number of animals used in these experiments varied from 1 to 84. Although not analysed statistically, sex, age, and breed of animals influenced the cysticerci recovery rate. Additionally, the cysticerci recovery rate and antibody-antigen levels were shown to increase with an increase in the dose of oncospheres and eggs inoculated in the animals. Contrasting results were reported in which the cysticerci recovery rate decreased with an increase in the dose of eggs inoculated. This review describes the various animal experiments using Taenia species that cause cysticercosis highlighting the animals used, age and their breed, the routes of infection used to induce disease and the sample size used, and the cysticerci recovery rate in these animal models.

Sections du résumé

BACKGROUND
Cysticercosis and Neurocysticercosis (NCC) can be studied using several animal species in experimental models which contributes to the understanding of the human form of the disease. Experimental infections of Taenia spp. are vital in explaining the modes of transmission of the parasite and helps the understanding of transmission of the parasite in humans and thus may be useful in designing therapeutic and immune-prophylactic studies to combat the disease. Thus, this systematic review aims to explore the existing experimental animal models to the understanding of cysticercosis in both humans and animals and elucidate the risk factors of cysticercosis and identify the Taenia spp. used in these models.
METHODOLOGY
We systematically identified all publications from the Web of Science, Google Scholar, and Pubmed regarding experimental animal models using Taenia spp. that cause cysticercosis in both humans and animals. 58 studies were identified for eligibility. Of these, only 48 studies met the inclusion criteria from which data extraction was done and presented descriptively.
RESULTS
Pigs, cattle, gerbils, mice, rats, voles, monkeys, cats, dogs, and goats were used in which T. solium, T. saginata, T. saginata asiatica, T. crassiceps and T. asiatica were studied. The routes used to induce disease were; oral, intravenous, subcutaneous, intramuscular, intraperitoneal, intraarterial, intracranial, intraduodenal, and surgical routes using eggs, oncospheres, and proglottids. Besides, the establishment of infection using eggs and oncospheres was affected by the route used to induce infection in the experimental animals. The cysticerci recovery rate in all the experimental studies was low and the number of animals used in these experiments varied from 1 to 84. Although not analysed statistically, sex, age, and breed of animals influenced the cysticerci recovery rate. Additionally, the cysticerci recovery rate and antibody-antigen levels were shown to increase with an increase in the dose of oncospheres and eggs inoculated in the animals. Contrasting results were reported in which the cysticerci recovery rate decreased with an increase in the dose of eggs inoculated.
CONCLUSION
This review describes the various animal experiments using Taenia species that cause cysticercosis highlighting the animals used, age and their breed, the routes of infection used to induce disease and the sample size used, and the cysticerci recovery rate in these animal models.

Identifiants

pubmed: 35853079
doi: 10.1371/journal.pone.0271232
pii: PONE-D-22-01651
pmc: PMC9295976
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0271232

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Vet Parasitol. 2002 Aug 30;108(1):41-8
pubmed: 12191898
Kaohsiung J Med Sci. 2006 Jan;22(1):1-13
pubmed: 16570562
J Parasitol. 1996 Dec;82(6):1032-4
pubmed: 8973419
Can J Vet Res. 1991 Jul;55(3):274-6
pubmed: 1889037
J Immunol. 1999 Jan 15;162(2):995-1002
pubmed: 9916725
Am J Pathol. 2015 Aug;185(8):2259-68
pubmed: 26216286
Adv Parasitol. 2020;108:133-173
pubmed: 32291084
Res Vet Sci. 1996 Jan;60(1):64-8
pubmed: 8745259
Int J Parasitol. 1996 Jan;26(1):45-8
pubmed: 9198595
Int J Parasitol. 1995 Dec;25(12):1443-50
pubmed: 8719956
BMC Med Res Methodol. 2014 Mar 26;14:43
pubmed: 24667063
J S Afr Vet Assoc. 1998 Dec;69(4):156-62
pubmed: 10192090
Vet Parasitol. 2016 Aug 15;226:97-103
pubmed: 27514893
Vet Parasitol. 2003 Feb 27;111(4):323-32
pubmed: 12559711
J Vet Med B Infect Dis Vet Public Health. 2002 Oct;49(8):371-2
pubmed: 12449244
Am J Trop Med Hyg. 2018 Aug;99(2):380-387
pubmed: 29893202
J Helminthol. 1992 Sep;66(3):198-204
pubmed: 1452995
Vet Parasitol. 2017 Oct 15;245:39-41
pubmed: 28969835
J Helminthol. 1990 Sep;64(3):223-31
pubmed: 2230032
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
J Helminthol. 2006 Sep;80(3):219-23
pubmed: 16923263
Int J Parasitol. 1992 Apr;22(2):235-8
pubmed: 1587689
PLoS Negl Trop Dis. 2019 Mar 14;13(3):e0007261
pubmed: 30870421
Res Vet Sci. 2011 Feb;90(1):84-8
pubmed: 20493507
Int J Parasitol. 2008 Aug;38(10):1191-8
pubmed: 18328486
Res Vet Sci. 2009 Apr;86(2):261-6
pubmed: 18752819
Vet Parasitol. 2002 Aug 30;108(1):49-62
pubmed: 12191899
Parasitol Res. 2005 May;96(2):95-101
pubmed: 15812671
J Helminthol. 1999 Jun;73(2):183-6
pubmed: 10431380
Acta Trop. 2018 Jul;183:92-94
pubmed: 29626435
J Parasitol. 2002 Feb;88(1):69-73
pubmed: 12053982
PLoS Biol. 2010 Jun 29;8(6):e1000412
pubmed: 20613859
Korean J Parasitol. 2000 Dec;38(4):237-44
pubmed: 11138316
Front Med China. 2007 Jul;1(3):258-63
pubmed: 24573862
Infect Immun. 2007 Nov;75(11):5158-66
pubmed: 17698575
Parasitology. 1997 Jan;114 ( Pt 1):85-8
pubmed: 9011078
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Ann Trop Med Parasitol. 2006 Mar;100(2):123-35
pubmed: 16492360
Radiology. 2003 May;227(2):309-13
pubmed: 12732691
Kisaengchunghak Chapchi. 1992 Dec;30(4):269-75
pubmed: 1297417
Vet Parasitol. 1996 Jan;61(1-2):49-59
pubmed: 8750683
Vet Parasitol. 2000 Dec 20;94(1-2):33-44
pubmed: 11078942
Brain Pathol. 2019 May;29(3):425-436
pubmed: 30368965
Parasite Immunol. 2017 Jul;39(7):
pubmed: 28467600
Infect Genet Evol. 2008 Mar;8(2):213-6
pubmed: 18243817
Front Immunol. 2019 Jul 11;10:1589
pubmed: 31354728
Ann Trop Med Parasitol. 1989 Aug;83(4):395-403
pubmed: 2604477
J Helminthol. 1994 Sep;68(3):265-6
pubmed: 7829849
Trop Anim Health Prod. 1981 Feb;13(1):37-40
pubmed: 7256871
Acta Trop. 2017 Jan;165:252-260
pubmed: 27140860
Vet Parasitol. 2009 Oct 14;164(2-4):223-31
pubmed: 19524368
PLoS Negl Trop Dis. 2021 Apr 27;15(4):e0009295
pubmed: 33905419
Parasitology. 2010 Mar;137(3):335-46
pubmed: 19835660
J Parasitol. 2007 Apr;93(2):238-41
pubmed: 17539403
Int J Parasitol. 1997 Jun;27(6):631-3
pubmed: 9229246
Vet Parasitol. 1999 Feb 25;81(2):129-35
pubmed: 10030755
Parasitol Res. 1990;76(4):351-4
pubmed: 2186408
PLoS Negl Trop Dis. 2015 Aug 07;9(8):e0003980
pubmed: 26252878
Acta Trop. 2017 Jan;165:121-132
pubmed: 26802488

Auteurs

Muloongo C Sitali (MC)

Department of Biomedical Sciences, School of Veterinary Medicine, University of Zambia, Lusaka, Zambia.

Veronika Schmidt (V)

Centre for Global Health, Institute of Health and Society, University of Oslo, Oslo, Norway.

Racheal Mwenda (R)

Department of Paraclinical Studies, School of Veterinary Medicine, University of Zambia, Lusaka, Zambia.

Chummy S Sikasunge (CS)

Department of Paraclinical Studies, School of Veterinary Medicine, University of Zambia, Lusaka, Zambia.

Kabemba E Mwape (KE)

Department of Clinical Studies, School of Veterinary Medicine, University of Zambia, Lusaka, Zambia.

Martin C Simuunza (MC)

Department of Disease Control, School of Veterinary Medicine, University of Zambia, Lusaka, Zambia.

Clarissa P da Costa (CP)

Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany.

Andrea S Winkler (AS)

Department of Neurology, Centre for Global Health, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany.

Isaac K Phiri (IK)

Department of Clinical Studies, School of Veterinary Medicine, University of Zambia, Lusaka, Zambia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH